CBSA Urges CMS to Implement MCIT Rule Without Delay

In January, CMS finalized a new rule called Medicare Coverage of Innovative Technologies (MCIT). The rule provides immediate national Medicare coverage for FDA-designated breakthrough devices and diag...

Learn More

Weekly Policy Update: Biden’s Spending Proposal Signals Key Healthcare Priorities

Last week the White House unveiled a $1.5 trillion discretionary spending request for the coming fiscal year. The request, which is only part of the President’s full budget proposal, is a sharp depart...

Learn More

Your Support Needed Now: State Bill Threatens Life Sciences Innovation

The Colorado state legislature is considering a bill that will create a drug review board with the power to set payment and reimbursement rates for medicines in Colorado. CBSA shares the goal of impro...

Learn More

Weekly Policy Update: CBSA Convenes Roundtable Discussion with Congressman Joe Neguse

CBSA convened a virtual roundtable this week with Congressman Joe Neguse, who represents Colorado’s second Congressional district. It was a great opportunity for leaders in our ecosystem to highlight...

Learn More

Weekly Policy Update: New Study Examines Impact of Federal Drug Pricing Proposal

Last week, the Council of State Bioscience Associations released a new study that shows the impact of foreign reference pricing on patient access to lifesaving medicines and investment in new treatmen...

Learn More

Weekly Policy Update: State Leaders Solicit Input on Colorado’s Stimulus Funding

Colorado and local governments are expected to receive billions of dollars from the 2021 American Rescue Plan. In an effort to better understand the needs and current economic challenges facing the st...

Learn More

Weekly Policy Update: CBSA Testifies on Local Impact of Drug Pricing Bill

This week CBSA testified in opposition to Senate Bill 175 in the Senate Health & Human Services Committee. The bill would create a prescription drug review board in Colorado that’s charged with re...

Learn More

Weekly Policy Update: CBSA Engages on Key Legislation

CBSA took new positions on several bills in the 2021 legislative session. Here is a recap of what happened this week. New Funding for Advanced Industries Grant Program: On Tuesday, the legislature pas...

Learn More

Policy + Advocacy: Legislature Passes New Funding for Advanced Industries Accelerator Grant Program

On Tuesday, the Colorado General Assembly passed Senate Bill 42, which includes a one-time, $10 million infusion for the Advanced Industries Accelerator Grant Program. Governor Polis is expected to si...

Learn More

Weekly Policy Update: CBSA Shares Survey Insights

The CBSA Policy + Advocacy team works to engage state and federal policymakers on issues that are critical to our members and Colorado’s life sciences ecosystem. Last month, CBSA conducted a survey to...

Learn More